Feb 3, 2023 · TNBC is an aggressive breast cancer subtype with frequent early metastasis and an urgent need for new therapies. TNBC is known to express EMT molecular markers (14-20) …

Aug 3, 2022 · TNBC is an aggressive breast cancer subtype with frequent early metastasis and an urgent need for new therapies. TNBC is known to express EMT molecular markers …

The advances from the most recent studies of lncRNAs in the EMT-related signal pathways of TNBC metastasis. We also discussed the clinical research, application, and challenges of …

Mar 4, 2021 · Triple negative breast cancers (TNBC) are a morphologically and genetically heterogeneous group of breast cancers with uncertain prediction of biological behavior and …

Mar 21, 2024 · In this study, we aimed to investigate the correlation between TROP2 expression levels and the EMT-related biological behavior of BC cells. In addition, we explored the …

Triple-negative breast cancer (TNBC) is a heterogeneous group of disease with a well-known association with epithelial-mesenchymal transition (EMT) and breast cancer stem cell …

Dec 14, 2018 · There is increasing evidence showing that epigenetic mechanisms are involved in the activation of EMT. The objective of this study is to epigenetically reverse the process of …

Mar 7, 2019 · Taken together, our data demonstrate that GSK3β is a potential target for TNBCs and suggest that GSK3β inhibitors could serve as selective inhibitors of EMT and CSC …

Jul 18, 2023 · Epithelial–mesenchymal transition (EMT) is an important biological process in tumor invasion and metastasis, and thus a potential indicator of the progression and drug …

Feb 26, 2021 · In this review, we summarized many signal pathways related to EMT involved in the transfer process. The advances from the most recent studies of lncRNAs in the EMT …